Global Retirement Partners, LLC Aurinia Pharmaceuticals Inc. Transaction History

Global Retirement Partners, LLC

  • $4.24 Billion
  • Q3 2025

A detailed history of Global Retirement Partners, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 2,280 shares of AUPH stock, worth $34,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,280
Previous 2,280 -0.0%
Holding current value
$34,998
Previous $19,000 31.58%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$6.75 - $10.44 $1,012 - $1,566
-150 Reduced 6.17%
2,280 $20,000
Q1 2024

Apr 23, 2024
SELL
$4.93 - $9.31 $493 - $931
-100 Reduced 3.95%
2,430 $12,000
Q4 2023

Jan 18, 2024
SELL
$7.13 - $9.49 $2,139 - $2,847
-300 Reduced 10.6%
2,530 $22,000
Q3 2023

Oct 13, 2023
SELL
$7.77 - $12.27 $77 - $122
-10 Reduced 0.35%
2,830 $21,000
Q2 2023

Jul 20, 2023
SELL
$8.96 - $11.69 $1,209 - $1,578
-135 Reduced 4.54%
2,840 $27,000
Q1 2023

May 05, 2023
SELL
$5.94 - $11.27 $1,485 - $2,817
-250 Reduced 7.75%
2,975 $32,000
Q4 2022

Feb 13, 2023
SELL
$4.11 - $8.14 $2,055 - $4,070
-500 Reduced 13.42%
3,225 $13,000
Q1 2022

Jul 14, 2022
SELL
$10.05 - $22.48 $6,030 - $13,488
-600 Reduced 13.87%
3,725 $42,000
Q4 2021

Jan 21, 2022
BUY
$17.78 - $33.08 $76,898 - $143,071
4,325 New
4,325 $99,000

Others Institutions Holding AUPH

# of Institutions
269
Shares Held
69.3M
Call Options Held
984K
Put Options Held
574K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $2.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email